Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021

Fig. 1

Anti-SARS-CoV-2 IgG levels measured in plasma from 501 individuals by ELISA during a cross-sectional survey in July 2021 in two rural villages Kwamasimba and Mkokola in north-eastern Tanzania, showing mean and standard deviation. The cut-off is represented by a dotted line. Plasma samples from before the COVID-19 pandemic were used as negative controls; a Danish convalescent sample and the WHO Standard [30] were used as positive control

Back to article page